By Robb M. Stewart

 

Medtronic PLC said Wednesday it has begun a pediatric clinical trial of its spinal tether for the treatment of scoliosis.

The medical-technology company said it enrolled its first patient and completed the first surgical procedure in its Braive IDE study, which will evaluate the safety and effectiveness of the growth modulation system for treatment of progressive adolescent idiopathic scoliosis.

The first patient was recruited by the Newcastle Upon Tyne Hospitals NHS Foundation Trust in England. The device is Medtronic's latest in the pediatric spine category, and the study's initiation reaffirms the company's commitment to continued innovation for pediatric patients, it said.

In morning trading, Medtronics shares were up 1% at $129.09, for a gain of 10% since the end of last year.

 

Write to Robb M. Stewart at robb.stewart@wsj.com

 

(END) Dow Jones Newswires

September 22, 2021 10:40 ET (14:40 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Medtronic Charts.
Medtronic (NYSE:MDT)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Medtronic Charts.